AI assistant
CLARIVATE PLC — Director's Dealing 2021
Mar 15, 2021
31500_dirs_2021-03-15_5980f9fb-6d74-4bdf-9517-866cd4cc6b0d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CLARIVATE Plc (CLVT)
CIK: 0001764046
Period of Report: 2021-03-11
Reporting Person: Ahmed Mukhtar (President, Science Group)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-11 | Ordinary Shares | M | 138743 | $6.91 | Acquired | 189453 | Direct |
| 2021-03-11 | Ordinary Shares | M | 20947 | $10.85 | Acquired | 210400 | Direct |
| 2021-03-11 | Ordinary Shares | F | 9534 | $22.76 | Disposed | 200866 | Direct |
| 2021-03-11 | Ordinary Shares | F | 1622 | $23 | Disposed | 199244 | Direct |
| 2021-03-11 | Ordinary Shares | F | 40918 | $22.77 | Disposed | 158326 | Direct |
| 2021-03-11 | Ordinary Shares | S | 107616 | $22.88 | Disposed | 50710 | Direct |
| 2021-03-12 | Ordinary Shares | M | 78155 | $10.85 | Acquired | 128865 | Direct |
| 2021-03-12 | Ordinary Shares | F | 36582 | $23.18 | Disposed | 92283 | Direct |
| 2021-03-12 | Ordinary Shares | S | 41573 | $23.28 | Disposed | 50710 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-11 | Stock Options | $6.91 | M | 138743 | Disposed | 2028-03-08 | Ordinary Shares (138743.0) | Direct |
| 2021-03-11 | Stock Options | $10.85 | M | 20947 | Disposed | 2028-03-08 | Ordinary Shares (20947.0) | Direct |
| 2021-03-12 | Stock Options | $10.85 | M | 78155 | Disposed | 2028-03-08 | Ordinary Shares (78155.0) | Direct |
Footnotes
F1: Represents shares withheld for payment of exercise price.
F2: The price is a weighted average price. The prices actually received ranged from $22.52 to $23.22. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3: The price is a weighted average price. The prices actually received ranged from $23.045 to $23.66. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range
F4: Represents the remaining portion of a March 8, 2018 grant of stock options. The reported stock options became exercisable on November 30, 2020.